Phase II trial of docetaxel in patients with stage III and IV non-small cell lung cancer. - Francis,P.A.; Rigas,J.R.; Kris,M.G.; Pisters,K.MW.; Orazem,J.P.; Woolley,K.J.; Heelan,R.T. (J Clin Oncol, 1994)